Pharmacotherapy for Adult Patients with Acute Respiratory Distress Syndrome

Acute (Adult) Respiratory Distress Syndrome

Acute respiratory distress syndrome (ARDS) is a common and devastating condition which can affect all adult patients eg, medical, surgical and obstetric patients. It occurs when non-cardiogenic pulmonary oedema (secondary to acute damage to the alveoli) leads to acute respiratory failure. Although the terms ARDS and ALI are used interchangeably, the American-European Consensus Conference Commit...

Acute (Adult) Respiratory Distress Syndrome

Acute respiratory distress syndrome (ARDS) is a common and devastating condition which can affect all adult patients eg, medical, surgical and obstetric patients. It occurs when non-cardiogenic pulmonary oedema (secondary to acute damage to the alveoli) leads to acute respiratory failure. Although the terms ARDS and ALI are used interchangeably, the American-European Consensus Conference Commit...

Pharmacotherapy for Acute Respiratory Distress Syndrome: Limited Success to Date

Extracorporeal support for patients with acute respiratory distress syndrome.

Extracorporeal membrane oxygen (ECMO) has been used for many years in patients with life-threatening hypoxaemia and/or hypercarbia. While early trials demonstrated that it was associated with poor outcomes and extensive haemorrhage, the technique has evolved. It now encompasses new technologies and understanding that the lung protective mechanical ventilation it can facilitate is inextricably l...

Biomarkers for patients with trauma associated acute respiratory distress syndrome

Trauma is a major factor that contributes to the risk for acute respiratory distress syndrome (ARDS). Biomarkers that predict the risk, diagnosis, treatment response and prognosis of ARDS after trauma have been widely investigated. In addition to their applications in clinical diagnosis and treatment, these biomarkers provide important insights into our understanding of the pathogenesis of ARDS...